Skip to main content
National Practice Guide · L3

CRO & CDMO Contract Disputes in China: Delays, Data Integrity, Batch Failure & Termination

Outsourcing does not outsource accountability to regulators—but it does create a second battlefield: service contracts, change orders, and evidence of who caused delay or data failure.

Updated13 Aug 2026
AudienceForeign businesses & individuals
Author China Law List Editorial · Reviewer Yu Xue · Last reviewed · 3 min read · Editorial policy · AI content policy · Disclaimer · Not legal advice — confirm current rules with counsel and authorities

At a glance

Practice: typical process stages

Four high-level stages — details and local variations are in the guide below.

  1. FrameMap facts to PRC rules
  2. PlanOptions, risks & timeline
  3. ExecuteFilings, contracts, forums
  4. ReviewCompliance & next steps
City hubs

Local guides & lawyers

Drill into city × practice hubs where available, or open the city legal market guide.

General information only. Life sciences regulation in China spans NMPA product rules, PIPL/data security, human genetic resources, anti-corruption, volume-based procurement, IP, and clinical trial regimes. Facts, licences, and enforcement practice change. This is not legal advice and does not create an attorney–client relationship. Instruct qualified PRC counsel (and foreign counsel where FDA/EMA/CFIUS paths apply) before you recall product, transfer samples, answer a raid, or file a patent challenge.

Life sciences & healthcare legal cluster: Hub · Dawn raid · VBP · Hospital AR · Exclusive agency · HGR · Trial injury · CRO/CDMO · Device liability · Labeling · SaMD · Patent linkage · License · FDA WL · MDR/IVDR · Internet hospital · Trade secrets · Pharma ads · Device distribution · Sources · Checklist

CRO: enrollment lag & timeline breach

Classic dispute: site activation and enrollment miss milestones; sponsor withholds fees or claims liquidated damages; CRO blames inclusion criteria, competitive trials, or sponsor protocol amendments. Drafting cures: objective milestone definitions, dependency schedules (what sponsor must supply), cure periods, and fee holdback tied to measurable KPIs—not vague “best efforts.”

Data integrity, misconduct & CRO liability

When monitors miss fabricated vitals or source-document gaps, sponsors face regulatory exposure first and civil recovery second. Contracts should specify audit rights, forensic cooperation, step-in rights, and indemnity for wilful misconduct or gross negligence. Scientific background: trial data compliance.

CDMO: batch failure, destruction & supply continuity

  • Failed batch: root cause (process, materials, equipment, specification), disposition, and who pays for API/drug product loss.
  • Tech transfer incomplete when commercial launch dates are fixed—delay damages vs limitation clauses.
  • IP and quality agreement alignment: who owns deviations, CAPA, and regulatory filing rights.
  • Dual-source strategy clauses that CDMOs try to block via exclusivity.

Termination, wind-down & final invoices

Early termination for convenience vs for cause changes the money. Sponsors want data, samples, and TMF/transfer packages; vendors want payment for work performed and non-cancellable third-party costs. Require a wind-down SOW within a fixed number of days, escrow for critical data, and clear residual licence terms.

Dispute forum & evidence

Many China-facing CTAs and CDMO MSAs use CIETAC/BAC arbitration or litigated PRC courts. Preserve eTMF, EDMS audit trails, email/WeChat project channels, batch records, and change-control logs early. Without contemporaneous records, “he said / she said” destroys both damages and defence.

Negotiation priorities for 2026 contracts

  • Safety and HGR cooperation clauses (not only quality) — HGR guide.
  • Cyber and cross-border data flow maps for eCOA/EDC hosts.
  • Step-in and replacement vendor rights after integrity events.
  • Liability caps with carve-outs for fraud, IP infringement, and personal injury where market-standard.

Subject injury & insurance · Hub

Need sector counsel?

Map your issue to a specialty desk: Life sciences & healthcare · Devices & IVD · Clinical & health data · Product liability · Industry hub.

Find counsel
Sources & trust

How to use this guide

This page is general information for orientation. It is not legal advice and does not create an attorney–client relationship. For methodology and AI-assisted drafting rules, see our Editorial Policy and AI Content Policy. Directory badge meaning is described in the Lawyer Verification Policy.

Prefer primary statutes, judicial interpretations, and official guidance when making decisions. Where this guide links to city hubs or lawyer listings, verify credentials and engagement terms directly with counsel. Full disclaimer · Request a consultation.

Directory

Verified Practice lawyers

China-based listings shown first. Browse lawyer profiles for practice, then request legal help.

Verified listingsconsultationChina-first directory sort

Browse practice directory →

Need counsel on practice?

Connect with listed lawyers to request legal help. No obligation.